(Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 72.26%77.63K | -55.39%27.19K | -67.35%175.19K | -51.40%44.28K | -70.10%24.9K | -68.37%45.07K | -72.27%60.94K | -18.75%536.63K | -43.99%91.11K | -26.74%83.28K |
Selling and administrative expenses | 218.61%56.04K | -83.20%4.65K | -50.12%70.89K | -17.12%21.13K | -78.67%4.5K | -56.67%17.59K | -49.63%27.67K | -64.16%142.13K | -55.90%25.5K | -39.97%21.1K |
-General and administrative expense | 218.61%56.04K | -83.20%4.65K | -50.12%70.89K | -17.12%21.13K | -78.67%4.5K | -56.67%17.59K | -49.63%27.67K | -64.16%142.13K | -55.90%25.5K | -39.97%21.1K |
Other operating expenses | -21.42%21.59K | -32.26%22.54K | -73.56%104.3K | -64.72%23.15K | -67.19%20.4K | -73.03%27.48K | -79.81%33.27K | 49.49%394.5K | -37.42%65.61K | -20.82%62.18K |
Operating profit | -72.26%-77.63K | 55.39%-27.19K | 67.35%-175.19K | 51.40%-44.28K | 70.10%-24.9K | 68.37%-45.07K | 72.27%-60.94K | 18.75%-536.63K | 43.99%-91.11K | 26.74%-83.28K |
Net non-operating interest income (expenses) | 42.76%7.43K | 73.42%7.85K | 238.80%27.15K | 99.30%7.96K | 289.18%9.46K | 381.57%5.2K | 792.70%4.53K | 612.27%8.01K | 337.46%3.99K | 353.54%2.43K |
Non-operating interest income | 40.92%7.53K | 71.61%7.95K | 207.03%27.62K | 96.23%8.06K | 262.56%9.59K | 313.95%5.34K | 385.34%4.64K | 348.01%9K | 262.17%4.11K | 277.18%2.64K |
Total other finance cost | -28.06%100 | -3.67%105 | -51.98%472 | -12.39%99 | -41.31%125 | -33.81%139 | -75.67%109 | 11.33%983 | -48.87%113 | 29.09%213 |
Other net income (expenses) | -85.53%22.56K | 0 | ||||||||
Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.53%22.56K | --0 | ---- |
Income before tax | -76.10%-70.21K | 65.72%-19.34K | 70.75%-148.04K | 58.31%-36.32K | 80.90%-15.44K | 69.54%-39.87K | 72.77%-56.42K | -0.52%-506.05K | -1,399.67%-87.12K | 28.54%-80.85K |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | -76.10%-70.21K | 65.72%-19.34K | 70.75%-148.04K | 58.31%-36.32K | 80.90%-15.44K | 69.54%-39.87K | 72.77%-56.42K | -0.52%-506.05K | -1,399.67%-87.12K | 28.54%-80.85K |
Net income continuous operations | -76.10%-70.21K | 65.72%-19.34K | 70.75%-148.04K | 58.31%-36.32K | 80.90%-15.44K | 69.54%-39.87K | 72.77%-56.42K | -0.52%-506.05K | -1,399.67%-87.12K | 28.54%-80.85K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -76.10%-70.21K | 65.72%-19.34K | 70.75%-148.04K | 58.31%-36.32K | 80.90%-15.44K | 69.54%-39.87K | 72.77%-56.42K | -0.52%-506.05K | -1,399.67%-87.12K | 28.54%-80.85K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -76.10%-70.21K | 65.72%-19.34K | 70.75%-148.04K | 58.31%-36.32K | 80.90%-15.44K | 69.54%-39.87K | 72.77%-56.42K | -0.52%-506.05K | -1,399.67%-87.12K | 28.54%-80.85K |
Diluted earnings per share | -50.15%-0.0041 | 73.34%-0.0011 | 75.00%-0.01 | 0 | 90.96%-0.0009 | 72.64%-0.0027 | 78.77%-0.0042 | 0.00%-0.04 | -150.00%-0.01 | -8.96%-0.01 |
Basic earnings per share | -50.15%-0.0041 | 73.34%-0.0011 | 75.00%-0.01 | 0 | 90.96%-0.0009 | 72.64%-0.0027 | 78.77%-0.0042 | 0.00%-0.04 | -150.00%-0.01 | -8.96%-0.01 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.